On December 2, a Director at Steris (STE), David B. Lewis, sold shares of STE for $302.3K.
Following David B. Lewis’ last STE Sell transaction on February 13, 2020, the stock climbed by 27.3%.
See today’s analyst top recommended stocks >>
Based on Steris’ latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $756 million and quarterly net profit of $106 million. In comparison, last year the company earned revenue of $737 million and had a net profit of $94.77 million. The company has a one-year high of $196.80 and a one-year low of $105.69. Currently, Steris has an average volume of 321.87K.
Based on 5 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $200.00, reflecting a -4.0% downside.
In the last 30 days, insiders have sold $302.3K worth of STE shares and purchased $49.31K worth of STE shares. The insider sentiment on Steris has been positive according to 51 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
David B. Lewis’ trades have generated a -7.7% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
STERIS Plc (Ireland) engages in the manufacture of medical and surgical equipment. The company was founded on December 22, 2016 and is headquartered in Dublin, Ireland.
